The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Precision-Panc Master Protocol: Personalizing treatment for pancreatic cancer ISRCTN14879538—Part of Precision-Panc United Kingdom.
 
Juan W. Valle
Honoraria - Ipsen
Consulting or Advisory Role - Agios; AstraZeneca; Delcath Systems; Genoscience Pharma; Incyte; Ipsen; Keocyt; Merck; Novartis; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics
Speakers' Bureau - Ipsen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Nucana
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb; Eisai
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; Karus Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Eisai
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Ono Pharmaceutical (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Colin J McKay
No Relationships to Disclose
 
Judith Dixon-Hughes
No Relationships to Disclose
 
James Paul
No Relationships to Disclose
 
Jamie Stobo
No Relationships to Disclose
 
Susie Cooke
No Relationships to Disclose
 
Christine Willshire
No Relationships to Disclose
 
Nicola Williams
No Relationships to Disclose
 
Fraser Duthie
No Relationships to Disclose
 
Andrew Biankin
Consulting or Advisory Role - AstraZeneca; Celgene; Clovis Oncology
 
David Kuang-Fu Chang
No Relationships to Disclose